Anika Therapeutics (ANIK) Gross Margin Growth (3y) (2013 - 2026)
Anika Therapeutics (ANIK) Gross Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | 567.00 |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | -100.00 |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | 59.00 |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | -196.00 |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -228.00 |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | 12.00 |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | -61.00 |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Anika Therapeutics | 285.93 Mn | 247.52 Mn | 21.24 Mn | -25.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -25.00 |
| Mar 31, 2026 | 392.00 |
| Dec 31, 2025 | 19,810.00 |
| Sep 30, 2025 | -55.00 |
| Jun 30, 2025 | -1,179.00 |
| Mar 31, 2025 | -332.00 |
| Dec 31, 2024 | 534.00 |
| Sep 30, 2024 | 743.00 |
| Jun 30, 2024 | 1,213.00 |
| Mar 31, 2024 | 422.00 |
| Dec 31, 2023 | -25,036.00 |
| Sep 30, 2023 | 544.00 |
| Jun 30, 2023 | 2,060.00 |
| Mar 31, 2023 | 35.00 |
| Dec 31, 2022 | -20,640.00 |
| Sep 30, 2022 | -2,339.00 |
| Jun 30, 2022 | -1,483.00 |
| Mar 31, 2022 | -1,101.00 |
| Dec 31, 2021 | -2,340.00 |
| Sep 30, 2021 | -1,085.00 |